News
Wellsheet Partners with athenahealth’s Marketplace Program to Improve EHR Productivity and Reduce Clinician Burnout
Concarlo Therapeutics Hires Vadim Shepel as Chief Business & Operating Officer, Completing Build-out of Company’s Core Executive Team
Senior Leader Brings Deep Biotech and Pharmaceutical Industry Experience
Relmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial
Company Continues Commercial Preparations in Advance of Phase III Clinical Trial Readouts for REL-1017 in Major Depressive Disorder Expected in 2022
Wellsheet Recognized as a Sample Vendor in Smart EHR UI in a Gartner Report
Smart EHR UI Critical as Healthcare Burnout and Turnover Reach Record Levels, Jeopardizing Patient Care and the Bottom Line of Health Systems
KaloCyte Closes Investment from New York Blood Center
This funding will be used to support KaloCyte as it scales up in advance of human trials
Eliksa Therapeutics launched with University of Utah’s commercial and clinical-stage regenerative medicine technology
Founding investors include Militia Hill Ventures and University of Utah
Renovacor Announces Pipeline Expansion with New Research Program for Multiple Genetic Segments of Arrhythmogenic Cardiomyopathy
Research collaboration with the University of Utah’s Nora Eccles Harrison Cardiovascular Research and Training Institute expands pipeline with the addition of an AAV gene therapy program for multiple genetic segments of arrhythmogenic cardiomyopathy